Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lin-Miao Guo"'
Publikováno v:
Pharmaceutical Fronts, Vol 04, Iss 02, Pp e43-e60 (2022)
Abstract Lipid-based nanocarriers have been extensively investigated for drug delivery due to their advantages including biodegradability, biocompatibility, nontoxicity, and nonimmunogenicity. However, the shortcomings of traditional lipid-based nan
Externí odkaz:
https://doaj.org/article/c8849fc0766a4195bfd35b4187facac2
Autor:
Jing-jing Zhu, Lin-miao Guo, Mingshu Chen, Yong Gan, Xinxin Zhang, Yunqiu Miao, Xin Zhou, Rui Wang
Publikováno v:
Acta Pharmacol Sin
Lung cancer is one of the leading causes of cancer-related death worldwide. Various therapeutic failed in the effective treatment of the lung cancer due to their limited accumulation and exposure in tumors. In order to promote the chemotherapeutics d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375ea581a403649192b5638a68468ba0
https://doi.org/10.1038/s41401-020-00594-0
https://doi.org/10.1038/s41401-020-00594-0
Autor:
Rui Wang, Yong Gan, Yu Qiu, Xin Zhou, Kun Qian, Lin-miao Guo, Mingshu Chen, Yunqiu Miao, Xinxin Zhang
Publikováno v:
Nano letters. 21(14)
Triple-negative breast cancer (TNBC) is an aggressive disease with a high recurrence rate and poor outcomes in clinic. In this study, inspired by the enriched innate immune cell type tumor-associated macrophages (TAMs) in TNBC, we proposed a matrix m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f25cf4e3baefbc0fc0cf93b5022517
https://pubmed.ncbi.nlm.nih.gov/34240603
https://pubmed.ncbi.nlm.nih.gov/34240603